Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 13,871 shares at $7.78 ($108K) on 2026-02-13, disclosed to the SEC on 2026-02-18.
Scheduled sale ($108k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |
| CRBP | BUY | 2022-08-11 | $988 | — | Filing → |